Expression of FGF8, FGF18, and FGFR4 in Gastroesophageal Adenocarcinomas

Expression of FGF8, FGF18, and FGFR4 in Gastroesophageal Adenocarcinomas

Even though distinctive advances in the field of esophageal cancer therapy have occurred over the last few years, patients’ survival rates remain poor. FGF8, FGF18, and FGFR4 have been identified as promising biomarkers in a number of cancers; however no data exist on expression of FGF8, F...

Full description

Bibliographic Details
Main Authors: Gerd Jomrich, Xenia Hudec, Felix Harpain, Daniel Winkler, Gerald Timelthaler, Thomas Mohr, Brigitte Marian, Sebastian F. Schoppmann
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Cells
Subjects:
FGF8
FGF18
FGFR4
adenocarcinoma of the esophagogastric junction
neoadjuvant therapy
Online Access:https://www.mdpi.com/2073-4409/8/9/1092

Internet

https://www.mdpi.com/2073-4409/8/9/1092

Similar Items